Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating Activities    
Net income (loss) [1] $ 178,320 $ (382,821)
Adjustments to reconcile net income (loss) to net cash used in operating activities [1] (495,930) 372,588
Net cash used in operating activities [1] (317,610) (10,233)
Investing Activities    
Purchases and originations of loans held for investment [1] (2,084,750) (2,335,404)
Proceeds/payments received on loans held for investment [1] 1,581,575 1,445,778
Purchases and originations of loans held for investment, subject to nonrecourse debt [1] (31,080) (63,551)
Proceeds/payments on loans held for investment, subject to nonrecourse debt [1] 671,528 1,082,012
Proceeds on sale of mortgage servicing rights (“MSR”) [1] 5,516 85,628
Acquisition of American Advisors Group net assets [1] 0 (140,854)
Proceeds from sale of businesses (net of cash transferred) [1] 3,000 71,166
Other investing activities, net [1] (191) (5,444)
Net cash provided by investing activities [1] 145,598 139,331
Financing Activities    
Proceeds from issuance of HMBS related obligations [1] 1,457,360 1,553,957
Payments on HMBS related obligations [1] (1,622,531) (1,433,751)
Proceeds from issuance of nonrecourse debt [1] 813,870 1,695,339
Payments on nonrecourse debt [1] (630,287) (1,378,154)
Proceeds from other financing lines of credit [1] 4,492,107 3,530,606
Payments on other financing lines of credit [1] (4,366,018) (4,133,161)
Changes in notes payable [1] 27,047 12,340
Other financing activities, net [1] (3,998) (1,148)
Net cash provided by (used in) financing activities [1] 167,550 (123,972)
Effect of exchange rate changes on cash and cash equivalents 24 52
Net increase (decrease) in cash and cash equivalents and restricted cash (4,438) 5,178
Cash and cash equivalents and restricted cash, beginning of period [1] 224,801 277,436
Cash and cash equivalents and restricted cash, end of period [1] 220,363 282,614
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 44,258 66,341
Restricted cash 176,105 216,273
Total cash and cash equivalents and restricted cash, end of period [1] 220,363 282,614
Supplementary Cash Flows Information    
Cash paid for interest 274,887 210,840
Loans transferred to loans held for sale, at fair value, from loans held for investment, at fair value 5,424 3,685
Class A Common Stock    
Financing Activities    
Issuance of Class A Common Stock [1] $ 0 $ 30,000
[1] Amounts presented contain results from both continuing and discontinued operations. Refer to Note 4 - Discontinued Operations for additional information regarding cash flow associated with the results of discontinued operations.